Longitudinal assessment of serum anticholinergic activity in delirium of the elderly

Journal of Psychiatric Research

Volumn 46, Issue 10, 2012, Pages 1339-1345

  van Munster, Barbara C ^a,b   Thomas, Christine ^c   Kreisel, Stefan H ^c   Brouwer, Jantien P ^a   Nanninga, Stephanie ^a   Kopitz, Juergen ^d   de Rooij, Sophia E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b GELRE HOSPITALS   (Netherlands)

^c EVANGELISCHES KRANKENHAUS   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anticholinergics; Biomarker; Cognitive impairment; Delirium; Dementia; Geriatrics; Hip fracture; Old age

Indexed keywords

HYDROCORTISONE; INTERLEUKIN 6;

AGED; ANTICHOLINERGIC EFFECT; ARTICLE; COGNITIVE DEFECT; DELIRIUM; GERIATRICS; HIP FRACTURE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 84865568781     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.06.015     Document Type: Article

References (44)

1. Bruce A.J., Ritchie C.W., Blizard R., Lai R., Raven P. The incidence of delirium associated with orthopedic surgery: a meta-analytic review. International Psychogeriatrics 2007, 19:197-214.
2. Campbell N., Boustani M., Limbil T., Ott C., Fox C., Maidment I., et al. The cognitive impact of anticholinergics: a clinical review. Clinical Interventions in Aging 2009, 4:225-233.
3. Carnahan R.M., Lund B.C., Perry P.J., Pollock B.G., Culp K.R. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. The Journal of Clinical Pharmacology 2006, 46:1481-1486.
4. Cerejeira J., Firmino H., Vaz-Serra A., Mukaetova-Ladinska E.B. The neuroinflammatory hypothesis of delirium. Acta Neuropathologica 2010, 119:737-754.
5. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987, 40:373-383.
6. Chew M.L., Mulsant B.H., Pollock B.G. Serum anticholinergic activity and cognition in patients with moderate-to-severe dementia. American Journal of Geriatric Psychiatry 2005, 13:535-538.
7. Cox E.A., Kwatra S.G., Shetty S., Kwatra M.M. Flaws in the serum anticholinergic activity assay: implications for the study of delirium. Journal of the American Geriatrics Society 2009, 57:1707-1708.
8. Dasgupta M., Dumbrell A.C. Preoperative risk assessment for delirium after noncardiac surgery: a systematic review. Journal of the American Geriatrics Society 2006, 54:1578-1589.
9. de Jonghe J.F. Differentiating between demented and psychiatric patients with the Dutch version of the IQCODE. International Journal of Geriatric Psychiatry 1997, 12:462-465.
10. Flacker J.M., Cummings V., Mach J.R., Bettin K., Kiely D.K., Wei J. The association of serum anticholinergic activity with delirium in elderly medical patients. American Journal of Geriatric Psychiatry 1998, 6:31-41.
11. Flacker J.M., Lipsitz L.A. Serum anticholinergic activity changes with acute illness in elderly medical patients. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 1999, 54:M12-M16.
12. Fong T.G., Tulebaev S.R., Inouye S.K. Delirium in elderly adults: diagnosis, prevention and treatment. Nature Reviews Neurology 2009, 5:210-220.
13. Golinger R.C., Peet T., Tune L.E. Association of elevated plasma anticholinergic activity with delirium in surgical patients. American Journal of Psychiatry 1987, 144:1218-1220.
14. Hori K., Konishi K., Watanabe K., Uchida H., Tsuboi T., Moriyasu M., et al. Influence of anticholinergic activity in serum on clinical symptoms of Alzheimer's disease. Neuropsychobiology 2011, 63:147-153.
15. Inouye S.K. Delirium in older persons. The New England Journal of Medicine 2006, 354:1157-1165.
16. Inouye S.K., van Dyck C.H., Alessi C.A., Balkin S., Siegal A.P., Horwitz R.I. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Annals of Internal Medicine 1990, 113:941-948.
17. Jorm A.F. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychological Medicine 1994, 24:145-153.
18. Mach J.R., Dysken M.W., Kuskowski M., Richelson E., Holden L., Jilk K.M. Serum anticholinergic activity in hospitalized older persons with delirium: a preliminary study. Journal of the American Geriatrics Society 1995, 43:491-495.
19. Maclullich A.M., Ferguson K.J., Miller T., de Rooij S.E., Cunningham C. Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. Journal of Psychosomatic Research 2008, 65:229-238.
20. Marcantonio E.R., Palihnich K., Appleton P., Davis R.B. Pilot randomized trial of donepezil hydrochloride for delirium after hip fracture. Journal of the American Geriatrics Society 2011, 59(Suppl. 2):S282-S288.
21. Marcantonio E.R., Rudolph J.L., Culley D., Crosby G., Alsop D., Inouye S.K. Serum biomarkers for delirium. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2006, 61:1281-1286.
22. Miller P.S., Richardson J.S., Jyu C.A., Lemay J.S., Hiscock M., Keegan D.L. Association of low serum anticholinergic levels and cognitive impairment in elderly presurgical patients. American Journal of Psychiatry 1988, 145:342-345.
23. Mulsant B.H., Pollock B.G., Kirshner M., Shen C., Dodge H., Ganguli M. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Archives of General Psychiatry 2003, 60:198-203.
24. Mussi C., Ferrari R., Ascari S., Salvioli G. Importance of serum anticholinergic activity in the assessment of elderly patients with delirium. Journal of Geriatric Psychiatry and Neurology 1999, 12:82-86.
25. Nebes R.D., Pollock B.G., Meltzer C.C., Saxton J.A., Houck P.R., Halligan E.M., et al. Serum anticholinergic activity, white matter hyperintensities, and cognitive performance. Neurology 2005, 65:1487-1489.
26. Plaschke K., Hill H., Engelhardt R., Thomas C., von Haken R., Scholz M., et al. EEG changes and serum anticholinergic activity measured in patients with delirium in the intensive care unit. Anaesthesia 2007, 62:1217-1223.
27. Plaschke K., Kopitz J., Mattern J., Martin E., Teschendorf P. Increased cortisol levels and anticholinergic activity in cognitively unimpaired patients. The Journal of Neuropsychiatry & Clinical Neurosciences 2010, 22:433-441.
28. Plaschke K., Thomas C., Engelhardt R., Teschendorf P., Hestermann U., Weigand M.A., et al. Significant correlation between plasma and CSF anticholinergic activity in presurgical patients. Neuroscience Letters 2007, 417:16-20.
29. Rubin D.B., Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics 1996, 52:249-264.
30. Sauerbrei W., Royston P. Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials. Journal of the Royal Statistical Society: Series A (Statistics in Society) 1999, 162:71-94.
31. Schuurmans M.J., Shortridge-Baggett L.M., Duursma S.A. The delirium observation screening scale: a screening instrument for delirium. Research and Theory for Nursing Practice 2003, 17:31-50.
32. Singer J.D., Willett J.B. Applied longitudinal data analysis: modeling change and event occurrence 2003, Oxford University Press.
33. Sloan E.P., Fenton G.W., Standage K.P. Anticholinergic drug effects on quantitative electroencephalogram, visual evoked potential, and verbal memory. Biological Psychiatry 1992, 31:600-606.
34. Thomas C., Hestermann U., Kopitz J., Plaschke K., Oster P., Driessen M., et al. Serum anticholinergic activity and cerebral cholinergic dysfunction: an EEG study in frail elderly with and without delirium. BMC Neuroscience 2008, 9:86.
35. Tollefson G.D., Montague-Clouse J., Lancaster S.P. The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home population. The Journal of Neuropsychiatry & Clinical Neurosciences 1991, 3:314-319.
36. Tune L., Carr S., Hoag E., Cooper T. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. American Journal of Psychiatry 1992, 149:1393-1394.
37. Tune L., Coyle J.T. Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Archives of General Psychiatry 1980, 37:293-297.
38. Tune L.E., Damlouji N.F., Holland A., Gardner T.J., Folstein M.F., Coyle J.T. Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet 1981, 318:651-653.
39. van Eijk M.M., Roes K.C., Honing M.L., Kuiper M.A., Karakus A., van der Jagt M., et al. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet 2010, 376:1829-1837.
40. van Munster B.C., Bisschop P.H., Zwinderman A.H., Korevaar J.C., Endert E., Wiersinga W.J., et al. Cortisol, interleukins and S100B in delirium in the elderly. Brain and Cognition 2010, 74:18-23.
41. van Munster B.C., Korevaar J.C., Zwinderman A.H., Levi M., Wiersinga W.J., De Rooij S.E. Time-course of cytokines during delirium in elderly patients with hip fractures. Journal of the American Geriatrics Society 2008, 56:1704-1709.
42. Vinogradov S., Fisher M., Warm H., Holland C., Kirshner M.A., Pollock B.G. The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. American Journal of Psychiatry 2009, 166:1055-1062.
43. Weinberger M., Samsa G.P., Schmader K., Greenberg S.M., Carr D.B., Wildman D.S. Comparing proxy and patients' perceptions of patients' functional status: results from an outpatient geriatric clinic. Journal of the American Geriatrics Society 1992, 40:585-588.
44. Zeevi N., Pachter J., McCullough L.D., Wolfson L., Kuchel G.A. The blood-brain barrier: geriatric relevance of a critical brain-body interface. Journal of the American Geriatrics Society 2010, 58:1749-1757.